Cannaray Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Reverse Merger
- (Cancelled)
- Investors
-
5
Cannaray General Information
Description
Producer of cannabis-based medical products intended to cater to the normal functioning of the immune system. The company provides hemp extract-based products such as oil, gummies, capsules, and creams that are mainly used for the treatment of chemotherapy-induced nausea, vomiting, epilepsy, multiple sclerosis, and chronic pain, enabling patients to get treated with less risk and side effects.
Contact Information
Website
cannaraycbd.comCorporate Office
- 1 Bow Churchyard
- London EC4M 9DQ
- England, United Kingdom
Corporate Office
- 1 Bow Churchyard
- London EC4M 9DQ
- England, United Kingdom
Cannaray Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Reverse Merger | 26-Sep-2022 | Cancelled | Generating Revenue | |||
| 3. Early Stage VC | 04-Apr-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 01-Jan-2021 | $9.5M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 09-Sep-2019 | $9.5M | $9.5M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cannaray Signals
Cannaray Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alpha Blue Ocean | Family Office | Minority | ||
| Channel 4 Ventures | Corporate Venture Capital | Minority | ||
| Three Bridges Private Capital | Venture Capital | Minority | ||
| Enexis (Sweden) | Venture Capital | Minority | ||
| Plutus Investment Group | Family Office | Minority |
Cannaray Acquisitions (2)
Cannaray’s most recent deal was a Merger/Acquisition with Aqualitas (Consumer Non-Durables) for . The deal was made on 12-Mar-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Aqualitas (Consumer Non-Durables) | 12-Mar-2024 | Merger/Acquisition | Specialty Retail | ||
| Therismos | 31-Jul-2019 | Merger/Acquisition | Distributors (Healthcare) |
Cannaray Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Therismos | Bromsgrove, United Kingdom | 2011 |
Cannaray FAQs
-
When was Cannaray founded?
Cannaray was founded in 2018.
-
Where is Cannaray headquartered?
Cannaray is headquartered in London, United Kingdom.
-
What is the size of Cannaray?
Cannaray has 16 total employees.
-
What industry is Cannaray in?
Cannaray’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Cannaray a private or public company?
Cannaray is a Private company.
-
What is Cannaray’s current revenue?
The current revenue for Cannaray is .
-
How much funding has Cannaray raised over time?
Cannaray has raised $22.6M.
-
Who are Cannaray’s investors?
Alpha Blue Ocean, Channel 4 Ventures, Three Bridges Private Capital, Enexis (Sweden), and Plutus Investment Group have invested in Cannaray.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process